Jingrong Jean Cui, Chief Scientific Officer at Turning Point Therapeutics, Inc. (TPTX), sold 11,380 shares at $53.67 ($602K) on 2019-12-11, disclosed to the SEC on 2019-12-12.
Open-market sale of $602k TPTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $52.72 | 8,928 | $471K | 78.1% |
| 2 | $53.67 | 2,452 | $132K | 21.9% |
| Total | $52.92 avg | 11,380 | $602K | 100% |
| Filing → |
| TPTX | SELL | 2020-05-21 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-12 | $1.2M | — | Filing → |
| TPTX | SELL | 2020-05-07 | $5.8M | — | Filing → |